Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients
Introduction: Secondary hyperparathyroidism (SHPT) is one of the components of chronic kidney disease-mineral bone disorder (CKD-MBD) with significant contribution to the morbidity and mortality among prevalent hemodialysis (HD) patients. Objectives: This multi-centric experience study aims to compa...
Saved in:
Main Authors: | Maha A. Behairy (Author), Osama Mahmoud (Author), Ayman Rabie Ibrahim (Author), Aber H. Baki (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis
by: Zhuolin Zhang, et al.
Published: (2021) -
THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
by: Sungjin Chung, et al.
Published: (2012) -
Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcet
by: Muhammed Ahmed Elhadedy, et al.
Published: (2023) -
Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation
by: Soliman Amin R., et al.
Published: (2016) -
Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
by: Jeong S, et al.
Published: (2016)